European Commission Drops Boehringer Case And Lauds Itself For Receding Patent Abuse
This article was originally published in The Pink Sheet Daily
Executive Summary
Boehringer Ingelheim's settlement with Almirall in an alleged patent abuse case shows that the EU pharmaceutical inquiry had a desired effect, the Commission maintains.